Analystreport

Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating.

Galmed Pharmaceuticals Ltd. - Ordinary Shares  (GLMD) 
Last galmed pharmaceuticals ltd. - ordinary shares earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: galmedpharma.investorroom.com